Enanta Pharmaceuticals
ENTA
ENTA
146 hedge funds and large institutions have $869M invested in Enanta Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 57 increasing their positions, 49 reducing their positions, and 22 closing their positions.
Holders
146
Holders Change
-13
Holders Change %
-8.18%
% of All Funds
2.36%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
10
Increased
57
Reduced
49
Closed
22
Calls
$10.6M
Puts
$176K
Net Calls
+$10.4M
Net Calls Change
-$94K
Top Buyers
1 |
B
1
Braidwell
Stamford,
Connecticut
|
$15.2M |
2 |
2
UBS AM
Chicago,
Illinois
|
$13.7M |
3 |
3
State Street
Boston,
Massachusetts
|
$70.3M |
4 |
4
BlackRock
New York
|
$175M |
5 |
CC
5
Commodore Capital
New York
|
$10.4M |